Oil futures settled lower to post a third-straight weekly loss on Friday, but moved up in extended trading after the U.S.

Elon Musk’s company made a splash earlier this week with a $25 billion bond deal, less than two weeks after it raised tens of ...

Fewer people are working from home — and that’s probably a good thing. In fact, new research suggests they might be happier and more successful if they go back to the office.

The equal-weighted version of the S&P 500 outperformed its traditional capitalization-weighted sibling this week by the ...

Americans have grown distrustful of artificial intelligence and worry it will eventually take their jobs. But for now, a huge boom in AI spending is powering the U.S. economy. The AI boom — or bubble, ...

SpaceX’s latest point of pride is its pivot toward becoming a provider of artificial-intelligence compute. But this new twist comes with its own slew of risks. Over the last two ...

As Cape Verde faces off against Saudi Arabia tonight, here’s a look at what could be next for the breakout World Cup star.

Dear Quentin, I read your article about Social Security (“Take the money while you can. I’m a CPA and tell my clients to take ...

Universe Pharmaceuticals agreed to acquire Best Praise International Limited in an all-stock deal valued at $10.8 million. Universe will pay for the acquisition with about 4.8 million shares of its ...

Why home loan yields don’t wait around for the central bank to make a move, and how to know if it’s finally time to refinance ...

Kevin Warsh, the new Federal Reserve chair, is helping coax Treasury yields lower by talking tough on inflation.

Lantheus Holdings's new drug application was rejected by the Food and Drug Administration's due to unresolved manufacturing issues at a third-party facility. The application was for LNTH-2501, an ...